|

Multimodal Survival Prediction Model for Colorectal Liver Metastases Post-Operation

RECRUITINGSponsored by Anhui Provincial Hospital
Actively Recruiting
SponsorAnhui Provincial Hospital
Started2017-02-01
Est. completion2026-09
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted

Summary

The purpose of this study is to construct and validate a multimodal survival prediction model by integrating 3D radiomics features derived from preoperative magnetic resonance imaging (MRI) with systemic clinical baseline indicators for patients with colorectal liver metastases (CRLM) after surgery. By combining micro-level radiomics signatures reflecting tumor micro-heterogeneity with macro-level clinical parameters (such as liver function and tumor biomarkers), the study aims to accurately evaluate individual post-operative prognostic risks. This quantitative tool will provide reliable decision support for clinicians to customize post-operative follow-up and personalized adjuvant treatment strategies.

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

Age \>= 18 years old. Confirmed diagnosis of colorectal cancer with liver metastases (CRLM). Underwent surgical resection for colorectal liver metastases. Preoperative liver magnetic resonance imaging (MRI) was performed with high-quality images available for 3D radiomics feature extraction.

Complete baseline clinical, laboratory, and post-operative follow-up survival data.

Exclusion Criteria:

Patients who received local ablation only (such as radiofrequency ablation) without surgical resection.

Preoperative MRI images with severe artifacts or poor quality that prevent high-throughput radiomics analysis.

Concurrent history of other primary malignant neoplasms. Missing key clinical variables or lost to follow-up immediately after surgical intervention.

Conditions6

CancerColorectal Liver MetastasesColorectal NeoplasmsLiver CancerLiver DiseaseLiver Neoplasms

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.